CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
The company’s Convidecia has received emergency-use authorization from the World Health Organization, becoming the third Chinese vaccine to get that nod Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted…
RELATED ARTICLES
-
Health Guard plans dual listing to fund HPV vaccine fight
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
- CHINA BULLETIN: Manufacturing Déjà Vu
- CHINA BULLETIN: Services, Trade Send Positive Signals
-
FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens
6185.HK 688185.SHG
